Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Drug Design, Development and Therapy|April 15, 2014
Tocilizumab in the treatment of rheumatoid arthritis and beyondAnjali Shetty, Rebekah Hanson, Peter Korsten, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 23, 2013
The novel role of IL-7 ligation to IL-7 receptor in myeloid cells of rheumatoid arthritis and collagen-induced arthritisZhenlong Chen, Seung-jae Kim, Nathan D Chamberlain, et al.Cellular & Molecular Immunology|May 17, 2020
IRAK4 inhibition: a promising strategy for treating RA joint inflammation and bone erosionSadiq Umar, Karol Palasiewicz, Katrien Van Raemdonck, et al.Cellular & Molecular Immunology|December 17, 2023
Metabolic reprogramming by Syntenin-1 directs RA FLS and endothelial cell-mediated inflammation and angiogenesisAnja Meyer, Stephanie R Zack, Wes Nijim, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2014
Ligation of TLR5 promotes myeloid cell infiltration and differentiation into mature osteoclasts in rheumatoid arthritis and experimental arthritisSeung-Jae Kim, Zhenlong Chen, Nathan D Chamberlain, et al.Annals of the Rheumatic Diseases|November 1, 2016
Differential impact of obesity on the pathogenesis of RA or preclinical models is contingent on the disease statusSeung-Jae Kim, Zhenlong Chen, Abdul B Essani, et al.Angiogenesis|January 13, 2018
IL-11 facilitates a novel connection between RA joint fibroblasts and endothelial cellsHatem A Elshabrawy, Michael V Volin, Abdul B Essani, et al.Annals of the Rheumatic Diseases|January 2, 2023
Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cellsAnja Meyer, Ryan E Sienes, Wes Nijim, et al.Cellular & Molecular Immunology|June 15, 2019
Macrophages are the primary effector cells in IL-7-induced arthritisSeung-Jae Kim, Huan J Chang, Michael V Volin, et al.Annals of the Rheumatic Diseases|November 10, 2018
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohortsElizabeth R Volkmann, Donald P Tashkin, Myung Sim, et al.Pageof 3